These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 8625153)
1. Significant reduction of medical costs by differentiation therapy with all-trans retinoic acid during remission induction of newly diagnosed patients with acute promyelocytic leukemia. The Japan Adult Leukemia Study Group. Takeshita A; Sakamaki H; Miyawaki S; Kobayashi T; Kuriyama K; Yamada O; Oh H; Takenaka T; Asou N; Ohno R Cancer; 1995 Aug; 76(4):602-8. PubMed ID: 8625153 [TBL] [Abstract][Full Text] [Related]
2. Morbidity and costs of remission induction therapy with all-trans retinoic acid compared with standard chemotherapy in acute promyelocytic leukemia. Eardley AM; Heller G; Warrell RP Leukemia; 1994 Jun; 8(6):934-9. PubMed ID: 8207987 [TBL] [Abstract][Full Text] [Related]
3. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience]. Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239 [TBL] [Abstract][Full Text] [Related]
4. All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York Study. Frankel SR; Eardley A; Heller G; Berman E; Miller WH; Dmitrovsky E; Warrell RP Ann Intern Med; 1994 Feb; 120(4):278-86. PubMed ID: 8291820 [TBL] [Abstract][Full Text] [Related]
5. Treatment of acute promyelocytic leukemia with all-trans retinoic acid: an update of the New York experience. Warrell RP; Maslak P; Eardley A; Heller G; Miller WH; Frankel SR Leukemia; 1994; 8 Suppl 2():S33-7. PubMed ID: 7815834 [TBL] [Abstract][Full Text] [Related]
6. Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195. Jurcic JG; Caron PC; Miller WH; Yao TJ; Maslak P; Finn RD; Larson SM; Warrell RP; Scheinberg DA Leukemia; 1995 Feb; 9(2):244-8. PubMed ID: 7869759 [TBL] [Abstract][Full Text] [Related]
7. Reduced medical costs and hospital days when using oral arsenic plus ATRA as the first-line treatment of acute promyelocytic leukemia. Jiang H; Liang GW; Huang XJ; Jiang Q; Han S; Shi LW; Zhu HH Leuk Res; 2015 Dec; 39(12):1319-24. PubMed ID: 26403986 [TBL] [Abstract][Full Text] [Related]
8. [Treatment of acute promyelocytic leukemia with all-trans retinoic acid and chemotherapy--multicenter trial of the Japan Adult Leukemia Study Group (JALSG)]. Asou N; Adachi K; Tamura J; Kanamaru A; Kageyama S; Hiraoka A; Omoto E; Akiyama H; Ohno R Gan To Kagaku Ryoho; 2000 Jul; 27(8):1168-73. PubMed ID: 10945012 [TBL] [Abstract][Full Text] [Related]
10. Treatment of acute promyelocytic leukemia with all-trans retinoic acid: an update of the New York experience. Warrell RP; Maslak P; Eardley A; Heller G; Miller WH; Frankel SR Leukemia; 1994 Jun; 8(6):929-33. PubMed ID: 8207986 [TBL] [Abstract][Full Text] [Related]
11. [All-trans retinoic acid (Tretinoin)]. Ohno R Gan To Kagaku Ryoho; 1997 Apr; 24(6):741-6. PubMed ID: 9126315 [TBL] [Abstract][Full Text] [Related]
12. All-trans retinoic acid therapy in relapsed/refractory or newly diagnosed acute promyelocytic leukemia (APL) in Japan. Ohno R; Ohnishi K; Takeshita A; Tanimoto M; Murakami H; Kanamaru A; Asou N; Kobayashi T; Kuriyama K; Ohmoto E Leukemia; 1994; 8 Suppl 3():S64-9. PubMed ID: 7808028 [TBL] [Abstract][Full Text] [Related]
13. Use of trans-retinoic acid in the treatment of acute promyelocytic leukemia. Dulaney AM; Murgatroyd RJ Ann Pharmacother; 1993 Feb; 27(2):211-4. PubMed ID: 8439701 [TBL] [Abstract][Full Text] [Related]
14. Constitutive expression of cellular retinoic acid binding protein II and lack of correlation with sensitivity to all-trans retinoic acid in acute promyelocytic leukemia cells. Zhou DC; Hallam SJ; Lee SJ; Klein RS; Wiernik PH; Tallman MS; Gallagher RE Cancer Res; 1998 Dec; 58(24):5770-6. PubMed ID: 9865735 [TBL] [Abstract][Full Text] [Related]
15. Retinoic acids in the treatment of acute promyelocytic leukemia. Castaigne S; Chomienne C; Daniel MT; Berger R; Miclea JM; Ballerini P; Degos L Nouv Rev Fr Hematol (1978); 1990; 32(1):36-8. PubMed ID: 2190178 [TBL] [Abstract][Full Text] [Related]
16. [Arsenic trioxide in combination with all-trans retinoic acid for acute promyelocytic leukemia: a systematic review and meta-analysis]. Xu SN; Chen JP; Liu JP; Xia Y Zhong Xi Yi Jie He Xue Bao; 2009 Nov; 7(11):1024-34. PubMed ID: 19912733 [TBL] [Abstract][Full Text] [Related]
17. Molecular remission induction with retinoic acid and anti-CD33 monoclonal antibody HuM195 in acute promyelocytic leukemia. Jurcic JG; DeBlasio T; Dumont L; Yao TJ; Scheinberg DA Clin Cancer Res; 2000 Feb; 6(2):372-80. PubMed ID: 10690513 [TBL] [Abstract][Full Text] [Related]
18. Treatment of newly diagnosed acute promyelocytic leukemia (APL) by a combination of all-trans retinoic acid (ATRA) and chemotherapy. French APL Group. Fenaux P; Chastang C; Degos L Leukemia; 1994; 8 Suppl 2():S42-7. PubMed ID: 7815836 [TBL] [Abstract][Full Text] [Related]
19. Clinical study of 9-cis retinoic acid (LGD1057) in acute promyelocytic leukemia. Soignet SL; Benedetti F; Fleischauer A; Parker BA; Truglia JA; Ra Crisp M; Warrell RP Leukemia; 1998 Oct; 12(10):1518-21. PubMed ID: 9766493 [TBL] [Abstract][Full Text] [Related]
20. Treatment of acute promyelocytic leukemia with all-trans retinoic acid. A five-year experience. Sun GL; Ouyang RR; Chen SJ; Gu YZ; Huang LA; Lu JX; Wang ZY Chin Med J (Engl); 1993 Oct; 106(10):743-8. PubMed ID: 8033606 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]